title: Effects of the mycotoxin fumonisin B(1) on cell death in human kidney cells and human lung fibroblasts in primary culture.
abstract: Fumonisins are mycotoxins produced by Fusarium verticillioides. The toxic effects of fumonisin B(1) (FB(1)) at the cellular level consist of a mixture of both necrosis and apoptosis. We studied the effect of FB(1) in human lung fibroblasts (NHLF) and human kidney epithelial cells (RPTEC) in primary culture. Apoptotic and necrotic cell death, collagen and fibronectin secretion were determined mainly after 14 days' exposure. The protein content of NHLF and RPTEC cells was slightly increased after 14 days' exposure to low FB(1) concentrations (0.1 or 1 microm). Caspase-3 activity tended to increase in NHLF and to decrease in RPTEC cells with higher FB(1) concentrations after 14 days' exposure. LDH release was slightly decreased in both cell types after 14 days. Collagen I and III secretion was enhanced in NHLF cells. Collagen III was decreased in RPTEC. Collagen IV was not changed in both cell types. Fibronectin secretion was uninfluenced in RPTEC and interim increased in NHLF. Furthermore LC-MS/MS studies did not give any hints for a metabolism of FB(1). Therefore, the main risk of prolonged FB(1) exposure seems to be altered collagen secretion pattern.
authors.affiliation: Julius-Bernstein-Institut für Physiologie, Martin-Luther-Universität Halle-Wittenberg, Germany. gerald.schwerdt@medizin.uni-halle.de
authors.forename: G
authors.initials: G
authors.lastname: Schwerdt
authors.forename: M
authors.initials: M
authors.lastname: Königs
authors.forename: H
authors.initials: H
authors.lastname: Holzinger
authors.forename: H U
authors.initials: HU
authors.lastname: Humpf
authors.forename: M
authors.initials: M
authors.lastname: Gekle
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D053148:Caspase 3 / Q000378:metabolism; D016923:Cell Death / Q000187:drug effects; D002478:Cells, Cultured; D024042:Collagen Type I / Q000378:metabolism; D024061:Collagen Type III / Q000378:metabolism; D024141:Collagen Type IV / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D005353:Fibronectins / Q000378:metabolism; D037341:Fumonisins / Q000633:toxicity*; D006801:Humans; D007668:Kidney / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008168:Lung / Q000166:cytology; D009183:Mycotoxins / Q000633:toxicity*; D013997:Time Factors
chemical_list: D024042:Collagen Type I; D024061:Collagen Type III; D024141:Collagen Type IV; D005353:Fibronectins; D037341:Fumonisins; D009183:Mycotoxins; D007770:L-Lactate Dehydrogenase; D053148:Caspase 3